Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes
Abstract The objective was to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of glucagon after injectable or nasal administration and confirm the appropriate therapeutic dose of nasal glucagon (NG) for adult patients. Six clinical studies with PK and five clinical studies with PD (...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | |
| Опубликовано: |
Wiley,
2024-07-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |